Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Hart

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Blood|October 24, 2014
Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011Peter W Collins, Benedict P Palmer, Elizabeth A Chalmers, et al.
The New England Journal of Medicine|May 6, 2020
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19Louise Bowles, Sean Platton, Nada Yartey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHCWolfgang Miesbach, Fariba Baghaei, Ana Boban, et al.
British Journal of Haematology|February 16, 2017
Treatment burden, haemostatic strategies and real world inhibitor screening practice in non-severe haemophilia APaul Batty, Steve K Austin, Kate Khair, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cellsSharyn Thomas, Shao-An Xue, Michela Cesco-Gaspere, et al.
Blood Cells, Molecules & Diseases|September 15, 2007
WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cellsHans J Stauss, Sharyn Thomas, Michela Cesco-Gaspere, et al.
Orphanet Journal of Rare Diseases|April 29, 2021
Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative studyDaniel P Hart, Brian R Branchford, Sarah Hendry, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 20, 2007
Monoclonal T-cell receptors: new reagents for cancer therapyHans J Stauss, Michela Cesco-Gaspere, Sharyn Thomas, et al.
Therapeutic Advances in Hematology|April 8, 2022
International consensus recommendations on the management of people with haemophilia BDaniel P Hart, Davide Matino, Jan Astermark, et al.
Thrombosis and Haemostasis|November 20, 2015
The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitorsAlice S van Velzen, Corien L Eckhardt, Nina Streefkerk, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Blood|October 24, 2014
Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011Peter W Collins, Benedict P Palmer, Elizabeth A Chalmers, et al.
The New England Journal of Medicine|May 6, 2020
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19Louise Bowles, Sean Platton, Nada Yartey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHCWolfgang Miesbach, Fariba Baghaei, Ana Boban, et al.
British Journal of Haematology|February 16, 2017
Treatment burden, haemostatic strategies and real world inhibitor screening practice in non-severe haemophilia APaul Batty, Steve K Austin, Kate Khair, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cellsSharyn Thomas, Shao-An Xue, Michela Cesco-Gaspere, et al.
Blood Cells, Molecules & Diseases|September 15, 2007
WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cellsHans J Stauss, Sharyn Thomas, Michela Cesco-Gaspere, et al.
Orphanet Journal of Rare Diseases|April 29, 2021
Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative studyDaniel P Hart, Brian R Branchford, Sarah Hendry, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 20, 2007
Monoclonal T-cell receptors: new reagents for cancer therapyHans J Stauss, Michela Cesco-Gaspere, Sharyn Thomas, et al.
Therapeutic Advances in Hematology|April 8, 2022
International consensus recommendations on the management of people with haemophilia BDaniel P Hart, Davide Matino, Jan Astermark, et al.
Thrombosis and Haemostasis|November 20, 2015
The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitorsAlice S van Velzen, Corien L Eckhardt, Nina Streefkerk, et al.
Pageof 5